GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (FRA:2HE) » Definitions » EV-to-EBITDA

HealthEquity (FRA:2HE) EV-to-EBITDA : 26.31 (As of Apr. 25, 2024)


View and export this data going back to 2014. Start your Free Trial

What is HealthEquity EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, HealthEquity's enterprise value is €6,870.1 Mil. HealthEquity's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was €261.1 Mil. Therefore, HealthEquity's EV-to-EBITDA for today is 26.31.

The historical rank and industry rank for HealthEquity's EV-to-EBITDA or its related term are showing as below:

FRA:2HE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 21.72   Med: 44.23   Max: 73.25
Current: 25.93

During the past 12 years, the highest EV-to-EBITDA of HealthEquity was 73.25. The lowest was 21.72. And the median was 44.23.

FRA:2HE's EV-to-EBITDA is ranked worse than
81.3% of 460 companies
in the Healthcare Providers & Services industry
Industry Median: 13.195 vs FRA:2HE: 25.93

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-25), HealthEquity's stock price is €74.50. HealthEquity's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was €0.590. Therefore, HealthEquity's PE Ratio for today is 126.27.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


HealthEquity EV-to-EBITDA Historical Data

The historical data trend for HealthEquity's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity EV-to-EBITDA Chart

HealthEquity Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 47.07 46.43 49.15 34.38 24.82

HealthEquity Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.38 25.95 27.95 26.26 24.82

Competitive Comparison of HealthEquity's EV-to-EBITDA

For the Health Information Services subindustry, HealthEquity's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HealthEquity's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where HealthEquity's EV-to-EBITDA falls into.



HealthEquity EV-to-EBITDA Calculation

HealthEquity's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6870.097/261.114
=26.31

HealthEquity's current Enterprise Value is €6,870.1 Mil.
HealthEquity's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €261.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity  (FRA:2HE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

HealthEquity's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=74.50/0.590
=126.27

HealthEquity's share price for today is €74.50.
HealthEquity's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.590.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


HealthEquity EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of HealthEquity's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity (FRA:2HE) Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

HealthEquity (FRA:2HE) Headlines

No Headlines